DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
“Kallay’s speech presages greater attention by U.S. antitrust authorities on anticompetitive conduct arising out of collective action by market dominant players within an SDO.” “Royalty-free” is an ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果